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Male reproduction has been given little attention in science and in medical practice. However, a recent metaanalysis on semen quality, which clearly
pointed to a decrease over the past 50 years, has been repeatedly quoted. Three recent reports have found that semen quality has declined among
candidate semen donors during the past 20 years. The evidence of decline in the quality of semen is not the only indicator that the human testis is
at risk. During the past 50 years, cancer of the testis has also become more common. This is a disorder of young men, and it is associated with a
high rate of other abnormalities of the testis including undescended testis and poor semen quality. Furthermore, the incidence of both hypospadias
and undescended testis has been reported to be rising in the general population. We believe that the evidence of declining semen quality should be
seen in the light of these trends in other reproductive disorders of men. However, the etiology is unknown. A recent hypothesis that links the trends
in the health of the male reproductive system to xenoestrogens in the environment is discussed. - Environ Health Perspect 103(Suppl
7):137-139(1995)
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Introduction
There is a growing concern that abnormal-
ities often associated with testicular cancer
are becoming more frequent; this is evi-
denced by an increasing incidence of tes-
ticular cancer (1-4) during the past
decades, as well as a possible increase in
the occurrence of cryptorchidism (5,6)
and hypospadias (7). Furthermore, these
changes have been accompanied by a
significant decline in semen quality
(8-10). The causes of the increasing inci-
dence of abnormalities in male reproduc-
tive function are not known. However, it
has been suggested that there may be an
etiological association. In addition, due to
the increased frequency of reproductive
abnormalities, it seems most probable that
they reflect adverse effects ofenvironmen-
tal or lifestyle factors rather than genetic
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changes. A hypothesis has been forwarded
that these changes in male reproductive
function may be caused by the impact of
an increasing environmental burden of
estrogens (11).
Testicular cancer develops from a non-
invasive stage of carcinoma in situ (CIS).
CIS cells have characteristics of malignant
primordial gonocytes. Therefore, testicular
cancer is believed to arise from fetal germ
cells (12). Reliable data indicate that there
has been a marked time-related increase in
the incidence of this neoplasm. Thus, the
Danish Cancer Registry has recorded a 3-
to 4-fold increase in the frequence oftestic-
ular germ cell cancer from the 1940s to the
1980s (1). Denmark is a high risk area for
testicular cancer. Similar increments have
been reported in countries with a lower
incidence, i.e., the United States (2) and
Scotland (4). Even in countries with a low
incidence oftesticular cancer (i.e., Finland),
an increase has been noted during the
past decades (3).
Cryptorchidism and hypospadias are
genitourinary abnormalities that arise dur-
ing fetal development. Increased incidence
of these abnormalities has recently been
reported; Chilvers et al. (5) reported an
apparent doubling of the frequency of
undescended testes from the 1950s to the
1970s. Similar results have been obtained
in other studies (6). Although the data on
hypospadias may be less convincing, they
seem to confirm that there has been an
increasing incidence (13).
A number ofstudies over the past 10 to
20 years have suggested that sperm counts
in men have declined; however, little
notice has been paid to these reports, possi-
bly because they were based on selected
groups of men (8). A systematic review of
the international literature on semen analy-
sis performed in normal men, including
almost 15,000 men in 61 publications
revealed a highly significant drop in mean
sperm counts from 113 million/ml in 1940
to 66 million/ml in 1990 (8) (Figure 1). In
addition, it appeared that the number of
menwith oligozoospermia (<20 million/ml)
and sperm counts in the lower end of the
normal range (20-40 million/ml) had
increased, whereas the percentage of those
with high sperm counts (> 100 million/ml)
(8) has decreased. Thus, the population of
menwith poor semen qualityhad increased.
These changes in sperm counts may have a
negative influence on male fertility.
Clinical experience indicates that there
might be an etiological association among
all the previously mentioned abnormalities
of male reproductive function. Testicular
cancer and cryptorchidism, as well as
hypospadias, are often associated with a
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Figure 1. Linear regression of mean sperm density
reported in 61 publications (represented by circles
whose area is proportional to the logarithm of the
number of subjects in study), each weighted according
to number ofsubjects, 1938 to 1990. Data from Carlsen
etal.(8).
histological pattern of impaired spermato-
genesis (13,14). In addition, it is well
known that testicular cancer arises more
often in maldescended testes (14), and
infertile men may have an increased risk of
testicular cancer.
Recently, it has been hypothesized that
male reproductive abnormalities may be
due to an increased level ofmaternal estro-
gens affecting the developing fetus (11).
The basis for the susceptibility to adverse
effects ofestrogens focuses on the effects of
this hormone on development and func-
tion of Sertoli cells of the fetal testis (15).
The proliferation and function of Sertoli
cells are controlled by the pituitary hor-
mone follicle-stimulating hormone (FSH)
(15), which in turn is under negative feed-
back regulation by estrogens (15). FSH
stimulates multiplication of Sertoli cells
and probably also regulates the secretion of
Mullerian-inhibiting substance (MIS)
(16), which is responsible for regression of
MUllerian ducts (17). Decrease in FSH
secretion from fetal pituitary-due to ele-
vated maternal estrogen levels-may have
an inverse effect on Sertoli-cell prolifera-
tion and secretion ofMIS. It has also been
suggested that impaired secretion of MIS
might lead to different types of intersex
conditions and cryptorchidism because
MIS may also play a role in the abdominal
phase of testicular descent (17). Further-
more, there seems to be evidence that MIS
controls division of early germ cells;
insufficient MIS production might cause
abnormal proliferation of germ cells; and
thereby plays a role in development ofCIS
germ cells, which give rise to testicular can-
cer in adult life (18).
Multiplication of Sertoli cells is largely
restricted to fetal and early neonatal life
(15,19) and is controlled by the produc-
tion ofFSH. Each Sertoli cell can support
only a finite number of germ cells to
develop into mature spermatozoa. A low
number ofSertoli cells could therefore be a
limiting factor in spermatogenesis.
Abnormal Sertoli-cell function may also
have a negative impact on Leydig cells and
consequently on the androgen production
and the virilization ofthe fetus.
The physiological basis for a possible
role ofestrogens in male reproductive dys-
function seems to be feasible. Since the lev-
els of maternal estrogens rise significantly
during pregnancy as a physiological phe-
nomenon, can an increase in maternal
estrogen levels have such a profound effect
on fetal genital organs? It should be kept in
mind that the critical events of testicular
development take place at the very early
stages offetal life, in a period that precedes
the marked physiological increase in
maternal estrogens. Increase in the basal
levels of estrogens at this very early period
of development may, therefore, have a
deleterious effect on development of male
reproductive organs. Furthermore, endoge-
nous estrogens are normally bound to sex
hormone-binding globulin (SHBG) with
high affinity whereas synthetic estrogens
are not (20); therefore, synthetic estrogens
may have a profound biological effect, even
when present in low concentration.
Experience with the synthetic estrogen
diethylstilbestrol (DES) speaks in favor of
the "estrogen hypothesis." Between 1950
and 1970, several million pregnant women
were treated with DES, which led to sub-
stantial increases in the incidence of cryp-
torchidism and hypospadias in the male
offspring, as well as decreased sperm counts
and probably also increased incidence of
testicular cancer in later life (21). Animal
data also seem to support the hypothesis.
Evidence for increasing levels of estro-
gens during the past half century comes
from several sources (11,22). Probably
most important have been the overall
change in diet and the increasing use of
environmental chemicals, many of which
are weak estrogens (23,24).
Although it seems likely that estrogens
may play an important role in the develop-
ment ofmale reproductive abnormalities, it
should be remembered that the estrogen
hypothesis (11) remains to be tested. It is
hoped that the growing awareness that
male reproductive function may be at risk
will stimulate both basic and clinical
research within this field that have received
relatively little attention in the past.
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